|
LYSMD3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.749200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.688360E-01 |
| Normal-vs-Stage2 |
3.374600E-01 |
| Normal-vs-Stage3 |
1.101830E-01 |
| Normal-vs-Stage4 |
1.460330E-02 |
| Stage1-vs-Stage2 |
7.409200E-01 |
| Stage1-vs-Stage3 |
8.020700E-03 |
| Stage1-vs-Stage4 |
4.186800E-04 |
| Stage2-vs-Stage3 |
8.146100E-02 |
| Stage2-vs-Stage4 |
2.854000E-02 |
| Stage3-vs-Stage4 |
4.458200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.404600E-01 |
| Normal-vs-AfricanAmerican |
1.680290E-03 |
| Normal-vs-Asian |
6.421400E-01 |
| Caucasian-vs-AfricanAmerican |
3.614000E-04 |
| Caucasian-vs-Asian |
6.304000E-01 |
| AfricanAmerican-vs-Asian |
4.602200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.321600E-01 |
| Normal-vs-Female |
4.134000E-01 |
| Male-vs-Female |
1.683190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.263850E-02 |
| Normal-vs-Age(41-60Yrs) |
8.878400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.547600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.976200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.593900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.970410E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.542350E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.832400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.579200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.406600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.798000E-01 |
| Normal-vs-Grade 2 |
4.040400E-02 |
| Normal-vs-Grade 3 |
3.981400E-01 |
| Normal-vs-Grade 4 |
4.76339999999631E-06 |
| Grade 1-vs-Grade 2 |
7.225000E-01 |
| Grade 1-vs-Grade 3 |
4.921600E-01 |
| Grade 1-vs-Grade 4 |
8.138100E-03 |
| Grade 2-vs-Grade 3 |
5.215500E-03 |
| Grade 2-vs-Grade 4 |
4.55680004840531E-09 |
| Grade 3-vs-Grade 4 |
1.416670E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.027900E-04 |
| Normal-vs-ccB subtype |
1.823690E-02 |
| ccA subtype-vs-ccB subtype |
1.13260000267346E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.747000E-01 |
| Normal-vs-N1 |
4.850100E-02 |
| N0-vs-N1 |
9.044300E-02 |
|
|
